791MO Clinical and tumor characteristics of patients (pts) with recurrence after pathologic response upon neoadjuvant ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma

Autor: J.M. Versluis, R. Elens, I.L.M. Reijers, A.M. Menzies, A.A.M. Van der Veldt, E. Kapiteijn, E.A. Rozeman, M.C. Klop, W. Van Houdt, R.P.M. Saw, C.L. Zuur, T.E. Pennington, B. van de Wiel, R.A. Scolyer, A. Broeks, A.C.J. van Akkooi, G.V. Long, C.U. Blank
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S906
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2022.07.917
Databáze: OpenAIRE